HAS Corporate Logo HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources
Contact Us
  • Sun images
  • Vector Images
HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources

Empower Your Innovations with Robust Evidence and Expert Management

Strategic Evidence Mastery: Guiding MedTech Through Comprehensive Study Design and Data Management"

Evidence Generation and Management - Services | HAS

In the MedTech sector, the value of an innovation is increasingly measured not just by its clinical efficacy but also by its economic impact and utility to payors. Our "Evidence Generation and Management" service is meticulously designed to guide companies through the complex landscape of economic study planning, data collection, and evidence management. We specialize in helping you define primary and secondary endpoints that are critical not only to demonstrate clinical effectiveness but also to underscore economic benefits, ensuring your technology aligns with the needs of healthcare systems and payors.

At the heart of our service is a commitment to robust, compliant evidence collection. We advise on the most effective methods for gathering real-world data that can withstand scrutiny and support the outcomes of comprehensive studies. This includes navigating the intricacies of economic modelling and demonstrating your product's value in tangible terms. By partnering with us, you ensure that your MedTech innovation is backed by a solid foundation of evidence that supports both clinical and economic decision-making, positioning your technology as a frontrunner in a competitive marketplace.

  • Tailored Study Design: Receive expert guidance in designing studies that accurately capture the clinical and economic impact of your MedTech solutions.
  • Compliance and Relevance: Ensure your evidence generation strategy is compliant with regulatory standards and relevant to payor requirements, facilitating smoother market access.
  • Robust Data Collection: Leverage our expertise in collecting and managing real-world data that supports the validity and reliability of your studies.
  • Economic Modelling Support: Gain insights into economic modelling techniques that highlight your product's cost-effectiveness and value to healthcare systems.
  • Decision-Maker Engagement: Empower your discussions with clinicians, payors, and decision-makers with solid evidence that demonstrates your technology's benefits.

Q: How do you determine the most relevant endpoints for our study?
A: We conduct a comprehensive analysis of your technology and market needs, working closely with you to identify endpoints that demonstrate both clinical effectiveness and economic value.

Q: What strategies do you use to ensure the data collected supports economic decision-making?
A: Our strategies include focusing on real-world evidence, patient-reported outcomes, and direct and indirect cost savings, ensuring the data is comprehensive and geared towards economic and payor decision-making.

Q: How do you manage and safeguard the data collected during studies?
A: We employ rigorous data management protocols, ensuring data integrity, confidentiality, and compliance with all regulatory standards throughout the collection, analysis, and reporting phases.

Enhancing Your Market Access Strategy: Our Additional Services

Market Access Analytics and Insight

Market Access Analytics and Insight

Our Market Research & Analysis service is uniquely tailored for the medical device & Life…

Read More
NICE HTA Strategy and Submission

NICE HTA Strategy and Submission

Navigate the complexities of NICE Health Technology Assessment (HTA) submissions with our expert strategic guidance.…

Read More
Dashboard Tools for Market Access

Dashboard Tools for Market Access

Navigating the complexities of market access requires not just data, but insights that can drive…

Read More
Sustainability and NET Zero for MedTech

Sustainability and NET Zero for MedTech

In an era where sustainability is not just an option but a necessity, MedTech companies…

Read More

Our Latest Insights.

 
  • Richard Tuson

Life Sciences Sector Plan Chapter Three: NHS Reform and Uptake

 
  • Richard Tuson

Life Sciences Sector Plan Chapter One: Innovation to Adoption

 
  • Richard Tuson

Life Sciences Sector Plan Chapter Two: Growth and Investment

 
  • Richard Tuson

NHS 10 Year Plan Chapter Two: Elective Care, Tariffs and the New Productivity Challenge

Health Analytical Solutions

  • About
  • Services
  • Blog
  • Resources
  • Contact Us

Services

  • Market Access Analytics and Insight
  • NICE HTA Strategy and Submission
  • Health Economics and Outcomes Research (HEOR)
  • Strategy Development
  • Reimbursement Strategy and Support
  • NHS Drug Tariff Submission Support
  • Private healthcare
  • Value Proposition Development for MedTech
  • Primary Care Market Insights
  • Stakeholder Engagement for Health Technologies
  • Sustainability and NET Zero for MedTech
  • Evidence Generation and Management
  • Dashboard Tools for Market Access
  • MedTech Sales Team Empowerment
  • NHS MedTech Business Case Formulation

Stay Up To Date

  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Contact Us

© Health Analytical Solutions 2025